Evidence map›Paper›PMID 39835223›Full record

ArticleIndian journal of clinical biochemistry : IJCB2025

Redefining the Reference Interval and Cut-Off Values of the Hematological and Biochemical Parameters and Deriving a Sensitive Predictive Marker for Crisis Events in Sickle Cell Disease.

Suprava Patel, Diksha Chandrakar, Preetam N Wasnik, Eli Mohapatra, Rachita Nanda, Seema Shah, Ashish Gupta

Abstract read
In one paragraph

Article in Indian journal of clinical biochemistry : IJCB, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Suprava PatelDepartment of Biochemistry, All India Institute of Medical Sciences, Raipur, Chhattisgarh India.ORCID 0000-0002-7449-1354
Diksha ChandrakarDepartment of Biochemistry, All India Institute of Medical Sciences, Raipur, Chhattisgarh India.
Preetam N WasnikDepartment of Medicine, All India Institute of Medical Sciences, Raipur, Chhattisgarh India.
Eli MohapatraDepartment of Biochemistry, All India Institute of Medical Sciences, Raipur, Chhattisgarh India.
Rachita NandaDepartment of Biochemistry, All India Institute of Medical Sciences, Raipur, Chhattisgarh India.
Seema ShahDepartment of Biochemistry, All India Institute of Medical Sciences, Raipur, Chhattisgarh India.
Ashish GuptaDepartment of Pathology, All India Institute of Medical Sciences, Raipur, Chhattisgarh India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The heterogeneity in clinical presentations in sickle cell disease (SCD) alters between crisis and steady state phases. Considering the pathophysiology, it is crucial to establish a disease-specific reference interval for hematological and biochemical parameters and identify the sensitive predictive markers for crisis. The case-control study included fifty-four healthy control, forty SCD cases in crisis state, and forty-six steady state cases. Blood samples were evaluated for complete blood count (CBC) and biochemical parameters. Red cell indices were calculated. 2.5th and 97.5th percentile values were delineated in the steady state cases as new reference interval. The new cut-off values were evaluated for sensitivity and specificity. The steady state cases reported a significant decrease in urea, sodium, Hb, Hct, and RBC count compared to the control group, whereas potassium, and red cell indices were higher. Compared to the steady state, the crisis state depicted a significant increase in urea, liver enzymes, leucocytes, inflammatory indices, and all red cell indices, whereas sodium, albumin, iron, Hb, Hct, and LMR were decreased. The revised 95 percentile ranges were sodium-132.35-143.65 mmol/L, potassium-3.75-6.09 mmol/L, albumin-2.9-5.0 g/dL, Hb-7.51-12.17 g/dL, RBC count-2.2-5.49 × 10 Supplementary Information: The online version contains supplementary material available at 10.1007/s12291-023-01158-9.

Indexed as

CBC profileCrisis statePercentileROC analysisSerum markersSteady state

Identifiers

PMID39835223
PMCPMC11741960

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.